Abstract Details
Michael D. Frost, MD
(Minnesota Epilepsy Group, PA)
PRESENTER |
No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Noah Berkowitz | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
E M. Bebin, MD, FAAN (UAB Epilepsy Center) | Dr. Bebin has received personal compensation for serving as an employee of Springworks Therapeutics. Dr. Bebin has received personal compensation for serving as an employee of Apertura Gene Therapy. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apertura. The institution of Dr. Bebin has received research support from NINDS. The institution of Dr. Bebin has received research support from FDA Orphan Drug Program. |